Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

125 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of branched-chain amino acid supplementation and walking exercise for preventing sarcopenia in patients with liver cirrhosis.
Hiraoka A, Michitaka K, Kiguchi D, Izumoto H, Ueki H, Kaneto M, Kitahata S, Aibiki T, Okudaira T, Tomida H, Miyamoto Y, Yamago H, Suga Y, Iwasaki R, Mori K, Miyata H, Tsubouchi E, Kishida M, Ninomiya T, Kohgami S, Hirooka M, Tokumoto Y, Abe M, Matsuura B, Hiasa Y. Hiraoka A, et al. Among authors: izumoto h. Eur J Gastroenterol Hepatol. 2017 Dec;29(12):1416-1423. doi: 10.1097/MEG.0000000000000986. Eur J Gastroenterol Hepatol. 2017. PMID: 29016470
Muscle volume loss as a prognostic marker in hepatocellular carcinoma patients treated with sorafenib.
Hiraoka A, Hirooka M, Koizumi Y, Izumoto H, Ueki H, Kaneto M, Kitahata S, Aibiki T, Tomida H, Miyamoto Y, Yamago H, Suga Y, Iwasaki R, Mori K, Miyata H, Tsubouchi E, Kishida M, Ninomiya T, Abe M, Matsuura B, Kawasaki H, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: izumoto h. Hepatol Res. 2017 May;47(6):558-565. doi: 10.1111/hepr.12780. Epub 2016 Aug 30. Hepatol Res. 2017. PMID: 27480045
Muscle volume loss a prognostic factor for death in liver cirrhosis patients and special relationship to portal hypertension.
Hiraoka A, Kitahata S, Izumoto H, Ueki H, Aibiki T, Okudaira T, Miyamoto Y, Yamago H, Iwasaki R, Tomida H, Mori K, Kishida M, Tsubouchi E, Miyata H, Ninomiya T, Hirooka M, Tokumoto Y, Abe M, Matsuura B, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: izumoto h. Hepatol Res. 2018 Feb;48(3):E354-E359. doi: 10.1111/hepr.12984. Epub 2017 Oct 18. Hepatol Res. 2018. PMID: 28940597
Abdominal Ultrasound Findings of Tumor-Forming Hepatic Malignant Lymphoma.
Kitahata S, Hiraoka A, Kudo M, Murakami T, Ochi M, Izumoto H, Ueki H, Kaneto M, Aibiki T, Okudaira T, Yamago H, Miyamoto Y, Iwasaki R, Tomida H, Mori K, Kishida M, Miyata H, Tsubouchi E, Hirooka M, Koizumi Y, Ninomiya T, Hiasa Y, Michitaka K. Kitahata S, et al. Among authors: izumoto h. Dig Dis. 2017;35(6):498-505. doi: 10.1159/000480138. Epub 2017 Oct 17. Dig Dis. 2017. PMID: 29040981
Impact of muscle volume and muscle function decline in patients undergoing surgical resection for hepatocellular carcinoma.
Hiraoka A, Otsuka Y, Kawasaki H, Izumoto H, Ueki H, Kitahata S, Aibiki T, Okudaira T, Yamago H, Miyamoto Y, Iwasaki R, Tomida H, Mori K, Miyata H, Tsubouchi E, Kishida M, Hirooka M, Abe M, Matsuura B, Ninomiya T, Mori I, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: izumoto h. J Gastroenterol Hepatol. 2018 Jun;33(6):1271-1276. doi: 10.1111/jgh.14058. Epub 2018 Jan 19. J Gastroenterol Hepatol. 2018. PMID: 29193248
Validation of Newly Proposed Time to Transarterial Chemoembolization Progression in Intermediate-Stage Hepatocellular Carcinoma Cases.
Izumoto H, Hiraoka A, Ishimaru Y, Murakami T, Kitahata S, Ueki H, Aibiki T, Okudaira T, Miyamoto Y, Yamago H, Iwasaki R, Tomida H, Mori K, Kishida M, Tsubouchi E, Miyata H, Ninomiya T, Kawasaki H, Hirooka M, Matsuura B, Abe M, Hiasa Y, Michitaka K, Kudo M. Izumoto H, et al. Oncology. 2017;93 Suppl 1:120-126. doi: 10.1159/000481242. Epub 2017 Dec 20. Oncology. 2017. PMID: 29258105 Free article.
Relative changes in handgrip strength and skeletal muscle volume in patients with chronic liver disease over a 2-year observation period.
Hiraoka A, Michitaka K, Izumoto H, Ueki H, Kitahata S, Aibiki T, Okudaira T, Yamago H, Miyamoto Y, Iwasaki R, Tomida H, Mori K, Miyata H, Tsubouchi E, Kishida M, Hirooka M, Abe M, Matsuura B, Ninomiya T, Hiasa Y. Hiraoka A, et al. Among authors: izumoto h. Hepatol Res. 2018 Jun;48(7):502-508. doi: 10.1111/hepr.13051. Epub 2018 Feb 6. Hepatol Res. 2018. PMID: 29314571
Proposed a simple score for recommendation of scheduled ultrasonography surveillance for hepatocellular carcinoma after Direct Acting Antivirals: multicenter analysis.
Hiraoka A, Kumada T, Ogawa C, Kariyama K, Morita M, Nouso K, Toyoda H, Tada T, Ochi M, Murakami T, Izumoto H, Ueki H, Kitahata S, Aibiki T, Okudaira T, Yamago H, Iwasaki R, Tomida H, Miyamoto Y, Mori K, Miyata H, Tsubouchi E, Kishida M, Ninomiya T, Michitaka K. Hiraoka A, et al. Among authors: izumoto h. J Gastroenterol Hepatol. 2019 Feb;34(2):436-441. doi: 10.1111/jgh.14378. Epub 2018 Jul 29. J Gastroenterol Hepatol. 2019. PMID: 29996177
Prediction of risk of falls based on handgrip strength in chronic liver disease patients living independently.
Hiraoka A, Tamura R, Oka M, Izumoto H, Ueki H, Tsuruta M, Yoshino T, Ono A, Aibiki T, Okudaira T, Yamago H, Suga Y, Iwasaki R, Mori K, Miyata H, Tsubouchi E, Kishida M, Ninomiya T, Hirooka M, Abe M, Matsuura B, Hiasa Y, Kino T, Yamamoto K, Michitaka K. Hiraoka A, et al. Among authors: izumoto h. Hepatol Res. 2019 Jul;49(7):823-829. doi: 10.1111/hepr.13322. Epub 2019 Mar 19. Hepatol Res. 2019. PMID: 30770617
Easy surveillance of muscle volume decline in chronic liver disease patients using finger-circle (yubi-wakka) test.
Hiraoka A, Izumoto H, Ueki H, Yoshino T, Aibiki T, Okudaira T, Yamago H, Suga Y, Iwasaki R, Tomida H, Mori K, Miyata H, Tsubouchi E, Kishida M, Ninomiya T, Hirooka M, Abe M, Matsuura B, Hiasa Y, Michitaka K. Hiraoka A, et al. Among authors: izumoto h. J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):347-354. doi: 10.1002/jcsm.12392. Epub 2019 Feb 21. J Cachexia Sarcopenia Muscle. 2019. PMID: 30793533 Free PMC article.
125 results